Skip to main content
OpenTrials

Clinical trial condition

LCA (Leber Congenital Amaurosis)

Explore clinical trials studying LCA (Leber Congenital Amaurosis). Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

LCA (Leber Congenital Amaurosis) trial results

Completed

Repeated Treatments of QLT091001 in Subjects With Leber Congenital Amaurosis or Retinitis Pigmentosa (Extension of Study RET IRD 01)

NCT01521793

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +8 more
Locations
  • The Chicago Lighthouse (University of Illinois at Chicago, Pangere Center for Inherited Retinal Disease) Chicago, Illinois, United States
  • Wilmer Eye Institute (Johns Hopkins University) Baltimore, Maryland, United States
  • Montreal Children's Hospital, McGill University Health Centre Montreal, Quebec, Canada
  • Institute for Ophthalmic Research, University of Tubingen Tübingen, Germany
View Trial Details
Completed

Safety/Proof of Concept Study of Oral QLT091001 in Subjects With Leber Congenital Amaurosis (LCA) or Retinitis Pigmentosa (RP) Due to Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT) Mutations

NCT01014052

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +8 more
Locations
  • The Chicago Lighthouse for People Who Are Blind or Visually Impaired (The Pangere Center For Inherited Retinal Diseases) Chicago, Illinois, United States
  • Wilmer Eye Institute (Johns Hopkins University) Baltimore, Maryland, United States
  • Scheie Eye Institute Philadelphia, Pennsylvania, United States
  • Montreal Children's Hospital, McGill University Health Centre Montreal, Quebec, Canada
View Trial Details

Related conditions